FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices

The FDA’s proactive approach to generative AI in healthcare marks a pivotal shift toward balancing rapid medical innovation with rigorous patient safety standards. By opening this dialogue, regulators aim to establish a framework that addresses the unique risks of opaque algorithms in high-stakes clinical decision-making.